Michael Sinclair Opiant Pharmaceuticals, Inc. (OPNT) insider trading activity

OPNT Quotes by TradingView

Michael Sinclair is Director of OPIANT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of OPNT, which is worth approximately $0. The most recent transaction as insider was on Mar 02, 2023, when has been sold 62,720 shares (Common Stock, par value $0.001 per share) at a price of $20.0 per share, resulting in proceeds of $1,254,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Michael Sinclair Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 02 2023
SELL
Sale (or disposition) back to the issuer
$1,254,400 $20.0 p/Share
62,720 Reduced 100.0%
0 Common Stock, par valu...
Jun 15 2022
SELL
Open market or private sale
$9,540 $10.6 p/Share
900 Reduced 4.47%
19,220 Common Stock
Jun 14 2022
SELL
Open market or private sale
$78,752 $10.9 p/Share
7,225 Reduced 26.42%
20,120 Common Stock
Jun 13 2022
SELL
Open market or private sale
$60,895 $11.09 p/Share
5,491 Reduced 16.72%
27,345 Common Stock
Jun 09 2022
SELL
Open market or private sale
$96,726 $12.25 p/Share
7,896 Reduced 19.39%
32,836 Common Stock
Jun 07 2022
SELL
Open market or private sale
$10,288 $12.86 p/Share
800 Reduced 1.93%
40,732 Common Stock
Jun 06 2022
SELL
Open market or private sale
$99,483 $12.94 p/Share
7,688 Reduced 15.62%
41,532 Common Stock
Jun 03 2022
SELL
Open market or private sale
$139,488 $13.59 p/Share
10,264 Reduced 17.26%
49,220 Common Stock
Jun 02 2022
SELL
Open market or private sale
$135,136 $13.88 p/Share
9,736 Reduced 14.07%
59,484 Common Stock
Aug 25 2021
SELL
Open market or private sale
$738,452 $14.69 p/Share
50,269 Reduced 25.87%
144,070 Common Stock, par valu...
Aug 25 2021
BUY
Exercise of conversion of derivative security
$251,345 $5.0 p/Share
50,269 Added 20.55%
194,339 Common Stock, par valu...
Aug 24 2021
SELL
Open market or private sale
$543,676 $15.71 p/Share
34,607 Reduced 19.37%
144,070 Common Stock, par valu...
Aug 24 2021
BUY
Exercise of conversion of derivative security
$173,035 $5.0 p/Share
34,607 Added 16.23%
178,677 Common Stock, par valu...
Aug 23 2021
SELL
Open market or private sale
$1,074,546 $16.5 p/Share
65,124 Reduced 31.13%
144,070 Common Stock, par valu...
Aug 23 2021
BUY
Exercise of conversion of derivative security
$325,620 $5.0 p/Share
65,124 Added 23.74%
209,194 Common Stock, par valu...
MS

Michael Sinclair

Director
Santa Monica, CA

Track Institutional and Insider Activities on OPNT

Follow OPIANT PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OPNT shares.

Notify only if

Insider Trading

Get notified when an Opiant Pharmaceuticals, Inc. insider buys or sells OPNT shares.

Notify only if

News

Receive news related to OPIANT PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OPNT